Navigation Links
High Demand for Weight Mgmt Product in European Pharmacies

Following completion of an exclusive Distribution Agreement with Laboratoire Physcience, France, for the rights to market LTP's satiety ingredient Olibra(R)//, as a single dose mini-shot, in France, Belgium, Spain, and Portugal, Physcience has successfully launched its Slim 10/10 product into these markets.

‘This is our most successful ever product launch into the French market, we have never seen such a success,’ says Jean Saint-Cricq, CEO Laboratoire Physcience. ‘During the quarter January/March 2006, Nielsen data has positioned Slim 10/10 as the lead product in terms of demand within the weight management category, throughout French pharmacies.

‘We have had such a positive response to Slim 10/10, from Health Professionals, Journalists and the trade sector. Our extensive above and below the line marketing support for the launch of Slim 10/10, including National TV campaigns throughout the whole of the launch period, has created high visibility & awareness of the brand.’

Slim 10/10 was successfully introduced in three other European countries: to date, Slim 10/10 is on shelf in 1600 pharmacies in Spain and at key retailers such as El Corte Ingles, in 1200 pharmacies in Belgium and in 400 pharmacies in Portugal.

Slim 10/10(TM) is a single effective 7.5g dose of Olibra(R), a natural ingredient, which can be safely taken orally, or added to normal food, taken at breakfast and/or lunch. The single dose product is packed in convenient strips for easy use.

LTP's functional food ingredient, Olibra(R), which addresses weight management, is derived from palm oil and oat oil. When applied as a food ingredient, the product has a scientifically substantiated effect of prolonging the feeling of fullness, resulting in significant reductions in energy intake at subsequent meals.

Source: PTI nes
'"/>




Page: 1

Related medicine news :

1. High Demand for a child vaccine
2. Demand for universal flu vaccination
3. Mentally Demanding Jobs Found To Reduce The Risk Of Alzheimer’
4. Research Fraud By Doctor – Probe Demanded
5. Drugs Manufacturers Capitalizing On The Surge In Demand For Bone Health Care
6. Bird Flu Likely To Reduce World Energy Demand
7. New Plastic Surgery Unit Set Up In Kolkata To Meet Ever-Increasing Consumer Demand
8. Sex Health Clinics Unable To Meet Increasing Demand
9. Bird Flu Scare Does Not Reduce Demand For Chicken
10. Demand For Diet Drugs On The Rise
11. High Demand For Circumcision In AIDS-Hit Swaziland
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected ... Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the position ... the end of 2018. Upon assuming the role of President and CEO on January ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a ... utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the ... a CBD form that can be easily incorporated into liquid products, while reducing costs ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Lori R. Somekh, ... member of ElderCounsel, a national organization of elder law and special needs planning attorneys. ... and rules. It also provides a forum to network with elder law attorneys nationwide,” ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that ... developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and ...
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
Breaking Medicine Technology: